United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

gulf drug llc belgium - 1 dose (0.5 ml) [1 vial powder (antigen) + 1 vial suspension (adjuvant)] - injection - 120 mcg/0.5 ml - immunologicals , vaccines-vaccines , antisera

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc.; distributor: glaxosmithkline philippines, inc. - respiratory syncytial virus vaccine (recombinant, adjuvanted) - powder for suspension for injection (im) - 120 mcg

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

glaxosmithkline k.k. - recombinant respiratory syncytial virus vaccine - injection

Bangladesh - English - DGDA (Directorate General of Drug Administration)

astro pharmaceuticals (ay) - vasakarista / vasakasav - liquid

United States - English - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - phentermine hydrochloride (unii: 0k2i505otv) (phentermine - unii:c045tql4wp) - phentermine hydrochloride 37.5 mg - phentermine hydrochloride, usp 37.5 mg is indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index ≥30 kg/m2 , or≥27 kg/m2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia). below is a chart of body mass index (bmi) based on various heights and weights. bmi is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. metric conversions are as follows: pounds ÷ 2.2 = kg; inches x 0.0254 = meters. the limited usefulness of agents of this class, including phentermine hydrochloride, [see clinical pharmacology ( 12.1 , 12.2 ) ] should be measured against possible risk factors inherent in their use such as those described below. •history of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart fail

United States - English - NLM (National Library of Medicine)

sinsin pharmaceutical co., ltd. - dl-camphor 17.05mg, l-menthol 45.45mg, mentha oil 22.73mg, methyl salicylate 45.45mg, zinc oxide 215.91mg - topical analgesic for temporary relief of minor aches and pains of muscles and joints associated with: - arthritis - simple backache - strains - bruises - sprains - on wounds or damaged skin - if you are allergic to aspirin or salicylates - with a heating pad - with, or at the same time as, other external analgesic products. if you are allergic to any ingredients of this product - do not use otherwise than directed. - avoid contact with the eyes, mucous membranes or rashes. - rash, itching or excessive skin irritation develops. - conditions worsen. - symptoms persist for more than 7 days. - symptoms clear up and occur again within a few days. if swallowed, get medical help or contact a poison control center right away.

United States - English - NLM (National Library of Medicine)

sinsin pharmaceutical co., ltd. - dl-camphor 34.10mg, l-menthol 90.90mg, mentha oil 45.46mg, methyl salicylate 90.90mg, zinc oxide 431.82mg - topical analgesic for temporary relief of minor aches and pains of muscles and joints associated with: - arthritis - simple backache - strains - bruises - sprains - on wounds or damaged skin - if you are allergic to aspirin or salicylates - with a heating pad - with, or at the same time as, other external analgesic products. if you are allergic to any ingredients of this product - do not use otherwise than directed. - avoid contact with the eyes, mucous membranes or rashes. - rash, itching or excessive skin irritation develops. - conditions worsen. - symptoms persist for more than 7 days. - symptoms clear up and occur again within a few days. ask a health professional before use if swallowed, get medical help or contact a poison control center right away.

United States - English - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - phentermine hydrochloride (unii: 0k2i505otv) (phentermine - unii:c045tql4wp) - phentermine hydrochloride tablets are indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index ≥ 30 kg/m2 , or ≥ 27 kg/m2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia). below is a chart of body mass index (bmi) based on various heights and weights. bmi is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. metric conversions are as follows: pounds ÷ 2.2 = kg; inches x 0.0254 = meters. height (feet, inches)   the limited usefulness of agents of this class, including phentermine, [see clinical pharmacology (12.1, 12.2) ] should be measured against possible risk factors inherent in their use such as those described below. - history of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive hear

Bangladesh - English - DGDA (Directorate General of Drug Administration)

jayson pharmaceuticals ltd. - artemether - injection - 80 mg/ml